Companies - Esperite

Price

 
Price
€ 0,18
Change
€ -0,01
Change %
-4,92%
Open
€ 0,19
High
€ 0,19
Low
€ 0,18
Volume
341.987

Profile

 
Profile
Esperite is the largest stem cell bank in Europe. The group specializes in isolating, collecting and preserving adult stem cells obtained from the blood of umbilical cords and umbilical tissue.
Industry
Biotechnology
Description
Companies in the biotechnology industry are performing research and development activities for the purpose of discovering new drugs and diagnostics. The turnover of these companies comes from sales of these products or the sale of licenses of drugs and diagnostic to other companies.

Key figures (2016)

 
The ratios below are calculated using the last known share price and the last known company financials.

Ratios per share

Price to Earnings
-0,224
Price to Earnings (3 years)
-0,276
Price to Earnings (5 years)
-0,229
Price to earnings growth
-
Price/cashflow
-0,345
Price/net cashflow
-3,366
Price/book value
-
Price to sales
0,072

Ratios for dividend

Dividend yield
-
Pay out
-

Valuation ratios

Market value/PE
-
Market value/turnover
0,072
Enterprise value/turnover
0,335

Return ratios

Return on private equity
-
Return on total equity
-19,80%
Profit margin
-32,04%

Risk ratios

Solvability
-
Solvability
-
Current ratio
0,580
Debt to Equity
-

Value invest ratios

Grahams Number
-
Grahams Value
-
Grahams Product
-
Grahams Product (3 years)
-

2016

 

Profit and loss

Net profit (x 1 mln)
€ -8,41
Turnover (x 1 mln)
€ 26,25
Cashflow(x 1 mln)
€ -5,47
Net cashflow(x 1 mln)
€ -0,56

Balance

Private equity (x 1 mln)
-
Foreign equity (x 1 mln)
-
Current assets (x 1 mln)
€ 9,54
Current liabilities (x 1 mln)
€ 16,44
Working capital (x 1 mln)
€ -6,90
Balance total (x 1 mln)
€ 42,48

Share

Outstanding shares (x 1 mln)
10,380
Price year-end
€ 1,31
Dividend per share
-
Earnings per share
€ -0,81
Cashflow per share
€ -0,53
Net cashflow per share
€ -0,05
Book value per share
-
Stockmarket value (x 1 mln)
€ 13,62

History

 
Year
2016
2015
2014
2013
2012
Net profit (x 1 mln)
€ -8,41
€ -7,06
€ -5,01
€ -3,51
€ -17,10
Turnover (x 1 mln)
€ 26,25
€ 27,52
€ 27,61
€ 30,57
€ 36,84
Price year-end
€ 1,31
€ 2,35
€ 1,49
€ 1,73
€ 2,30
Year high
€ 2,79
€ 3,94
€ 1,89
€ 2,44
€ 4,84
Year low
€ 1,15
€ 1,34
€ 1,48
€ 1,17
€ 2,17
Outstanding shares (x 1 mln)
10,380
10,031
9,729
9,729
9,676
Price to Earnings
-1,619
-3,339
-2,895
-4,795
-1,301
Earnings per share
€ -0,81
€ -0,70
€ -0,51
€ -0,36
€ -1,77
Dividends
-
-
-
-
-
Dividend yield
-
-
-
-
-
Pay out
-
-
-
-
-
Private equity (x 1 mln)
-
€ 15,25
€ 21,29
€ 26,77
€ 29,83
PE per share
-
€ 1,52
€ 2,19
€ 2,75
€ 3,08
Balance total (x 1 mln)
€ 42,48
€ 48,14
€ 46,88
€ 51,46
€ 55,62
Stockmarket value (x 1 mln)
€ 13,62
€ 23,57
€ 14,51
€ 16,83
€ 22,25

Company analysis

 

Analysis of profit indicators

Average profit per share (5 years)
€ -0,78
Standard deviation average profit
€ 0,67 (-86,10%)
Average annual growth rate
-56,85%
Compound annual growth percentage
-27,48%
© 2009 Skuzet. All Rights Reserved.